RPS19, one of the DEGs in metastatic breast cancer cells, is an immunosuppressive molecule expressed by metastatic breast cancer cells, and its interaction with C5AR1 of macrophages was also identified in the metastases of five lymph nodes[55]. Here, RPS19 is linked to breast carcinoma.